Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy

by on 5 de setembre de 2022 with No hi ha comentaris
  • Camacho, M., León, X., Pujol, A., Montezuma, L., Quer, M., & García, J. (2022). Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-022-02870-3 (En premsa)

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *